Varenicline tartrate

Overview

Varenicline (trade name Chantix in the USA and Champix in Canada, Europe and other countries, marketed by Pfizer, usually in the form of varenicline tartrate), is a prescription medication used to treat nicotine addiction. Varenicline is a nicotinic receptor partial agonist-it stimulates nicotine receptors more weakly than nicotine itself does. In this respect it is similar to cytisine and different from the nicotinic antagonist, bupropion, and nicotine replacement therapies (NRTs) like nicotine patches and nicotine gum. As a partial agonist it both reduces cravings for and decreases the pleasurable effects of cigarettes and other tobacco products. Through these mechanisms it can assist some patients to quit smoking.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Cardiovascular and blood system | nAChR

Product Information

• Catalog No.: B0084-067493
• CAS No.: 375815-87-5
• Molecular Formula: C17H19N3O6
• Molecular Weight: 361.35
• Purity: ≥ 95%
• Storage: 2-8 °C
• Solubility: Soluble in Methanol, DMSO, DMF, Ethanol

Source

Original product source